Black Patients With Dementia Are Less Likely to Get Appropriate Meds: Study

Protective Microglia Subtype Offers Potential New Therapeutic Pathway in Alzheimer’s Disease

Mount Sinai Awarded $4.5M BD2 Grant to Advance Research on the Biology of Bipolar Disorder

Mount Sinai Study Finds Chronic Traumatic Encephalopathy (CTE) Rare Among Individuals With Isolated Brain Injuries

Two Mount Sinai Research Papers Present Evidence of Distinct Molecular Differences Between Brain Tissue from Living People and Tissue Collected After Death

NIH Awards Mount Sinai Researchers $25 Million to Study Alzheimer’s Disease and Risk Among Chinese Americans

BDSRA Foundation Announces Mount Sinai Health System as New Site in Clinical Centers of Excellence Program

New Protein Interaction Map Sheds Light on How Brain Cell Communication Breaks Down in Alzheimer’s Disease

Mount Sinai Receives $8 Million from DataPhilanthropy to Accelerate Drug Discovery for CADASIL and Related Brain Disorders

The Mount Sinai Hospital Ranked Among Top in the Nation by U.S. News & World Report®

Mount Sinai Receives $3 Million Gift to Help Children With Spinal Cord Injuries and Cerebral Palsy Regain Mobility

New Framework for Characterizing Traumatic Brain Injury To Reveal More Detail About Patient’s Condition and Potential for Recovery